Intervention not reported
Timapiprant (1 RCT; 70 participants) · patients with moderate to severe eczema
The intervention showed no clear difference in timapiprant (1 RCT; 70 participants) (low certainty).
1 finding from 1 review
Gingivitis · Children aged 7 to 13 years with Down syndrome (mild to moderate ID); setting residential
1 finding from 1 review
Toothpaste with a plaque-disclosing agent vs conventional toothpaste, children with Down syndrome. Ainamo & Bay Gingival Bleeding Index, mean 10 days; percent mean difference 18 (intervention) vs 8 (control), P<0.001…
1 study · 40 participants
Very low
Plaque · Children aged 7 to 13 years with Down syndrome (mild to moderate ID); setting residential
1 finding from 1 review
Simplified Green & Vermillion Oral Hygiene Index (plaque), mean 10 days; percent mean difference 65 (intervention) vs 15 (control), P<0.0001 favouring the disclosing-agent toothpaste; 40 participants (SoF states 80,…
1 study · 40 participants
Very low
Intervention not reported
Clinical Global (CIBIC+) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Clinical Global: (CIBIC+) · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Cognitive function: ADAS‐Cog 70‐point scale · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Performance on ADL (NOSGER self care subscale) Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Behaviour: NOSGER disturbing behaviour subscale Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Binary outcomes · vascular dementia, mild‐to‐moderate severity
The review found no eligible studies for this question.
1 finding from 1 review
Memantine for dementia 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause discontinuation · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering at least one adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering at least one serious adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Number suffering agitation as an adverse event · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Cognitive Function (SIB) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Functional performance on activities of daily living: ADCS‐ADL19 54‐point scale · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Behaviour and Mood (NPI) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Binary outcomes · Alzheimer's disease (AD), moderate‐to‐severe
The review found no eligible studies for this question.
1 finding from 1 review
Memantine for dementia 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause discontinuation · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Number suffering at least one adverse event · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Number suffering at least one serious adverse event · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review